cyclohexyl-(cyclohexyliminomethylidene)-morpholin-4-yl-azanium
|
|
Descriptors Computed from Structure
Canonical SMILES:
C1CCC(CC1)N=C=[N+](C2CCCCC2)N3CCOCC3
Isomeric SMILES
C1CCC(CC1)N=C=[N+](C2CCCCC2)N3CCOCC3
InChI
InChI=1S/C17H30N3O/c1-3-7-16(8-4-1)18-15-20(17-9-5-2-6-10-17)19-11-13-21-14-12-19/h16-17H,1-14H2/q+1
Other Product
- 2,5-bis(chloranyl)cyclohexa-2,5-diene-1,4-diol
- 2,5-bis(chloranyl)benzene-1,4-diol
- 2,5-bis(chloranyl)phenol
- 2-oxidanylidenehexanedioic acid
- 2-oxidanylidene-3-sulfanyl-propanoic acid
- 3-oxidanylbenzaldehyde
- 3-azanylpropanal
- 2-azanyl-3-oxidanyl-benzoic acid
- 3-(3-hydroxyphenyl)propanoic acid
- 3-oxidanylidenehexanedioic acid
- 7-azanyl-4-[5-(hydroxymethyl)-3,4-bis(oxidanyl)oxolan-2-yl]-3,3a-dihydro-[1,3]thiazolo[4,5-d]pyrimidin-2-one
- [5-[5-azanyl-2,7-bis(oxidanylidene)-4H-[1,3]thiazolo[4,5-d]pyrimidin-3-yl]-3-(4-methylphenyl)carbonyloxy-oxolan-2-yl]methyl 4-methylbenzoate
- [6-(hydroxymethyl)-3,4,5-tris(oxidanyl)-2-phosphonooxy-oxan-2-yl] 3-oxidanyl-4-phosphonooxy-decanoate
- 14-ethenyl-4,4,10,13-tetramethyl-17-(6-methylheptan-2-yl)-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol
- [4,4,10,13-tetramethyl-17-(6-methylheptan-2-yl)-15-oxidanylidene-14-prop-2-enyl-1,2,3,5,6,9,11,12,16,17-decahydrocyclopenta[a]phenanthren-3-yl] benzoate
- 4,4,10,13-tetramethyl-17-(6-methylheptan-2-yl)-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthrene-3,14,15-triol
- 14-azanyl-4,4,10,13-tetramethyl-17-(6-methylheptan-2-yl)-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol
- 1-(hydroxymethyl)-4,4,10,13,14-pentamethyl-17-(6-methylhept-5-en-2-yl)-1,2,5,6,7,11,12,15,16,17-decahydrocyclopenta[a]phenanthrene-3,3-diol
- 2-[bis(fluoranyl)methyl]-4,4,10,13,14-pentamethyl-17-(6-methylhept-5-en-2-yl)-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol
- [4,4,10,13,14-pentamethyl-17-(6-methylheptan-2-yl)-15-oxidanyl-2,3,5,6,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl] benzoate
